These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 16182748

  • 1. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
    Veroux M, Puliatti C, Gagliano M, Cappello D, Macarone M, Vizcarra D, Spataro M, Di Mare M, Ginevra N, Veroux P.
    Transplant Proc; 2005; 37(6):2574-5. PubMed ID: 16182748
    [Abstract] [Full Text] [Related]

  • 2. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [Abstract] [Full Text] [Related]

  • 3. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
    Veroux M, Corona D, Ekser B, Giaquinta A, Tallarita T, De Martino C, Gentile F, Virgilio C, Gagliano M, Fiamingo P, Veroux P.
    Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL.
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [Abstract] [Full Text] [Related]

  • 7. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
    Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F.
    Transplantation; 1995 Jan 27; 59(2):230-4. PubMed ID: 7839446
    [Abstract] [Full Text] [Related]

  • 8. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.
    Madayag RM, Johnson LB, Bartlett ST, Schweitzer EJ, Constantine NT, McCarter RJ, Kuo PC, Keay S, Oldach DW.
    Transplantation; 1997 Dec 27; 64(12):1781-6. PubMed ID: 9422420
    [Abstract] [Full Text] [Related]

  • 9. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B.
    Clin Transplant; 2011 Dec 27; 25(1):E77-81. PubMed ID: 21039887
    [Abstract] [Full Text] [Related]

  • 10. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
    Berber I, Aydin C, Yigit B, Turkmen F, Titiz IM, Altaca G.
    Transplant Proc; 2005 Dec 27; 37(10):4173-5. PubMed ID: 16387070
    [Abstract] [Full Text] [Related]

  • 11. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V, Ingsathit A, Jirasiritham S.
    Transplant Proc; 2009 Dec 27; 41(1):213-5. PubMed ID: 19249516
    [Abstract] [Full Text] [Related]

  • 12. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L, Koepsell T, Manhart L, Ioannou G.
    Liver Transpl; 2009 Oct 27; 15(10):1343-50. PubMed ID: 19790164
    [Abstract] [Full Text] [Related]

  • 13. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E, Strasser SI, Koorey DJ, Verran D, McCaughan GW.
    Clin Transplant; 2006 Oct 27; 20(3):369-73. PubMed ID: 16824156
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.
    Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW.
    Liver Transpl; 2003 Oct 27; 9(10):1053-61. PubMed ID: 14526400
    [Abstract] [Full Text] [Related]

  • 15. Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.
    Akalin E, Ames S, Sehgal V, Murphy B, Bromberg JS.
    Clin Transplant; 2005 Jun 27; 19(3):364-6. PubMed ID: 15877799
    [Abstract] [Full Text] [Related]

  • 16. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.
    Mahboobi N, Tabatabaei SV, Blum HE, Alavian SM.
    Transpl Infect Dis; 2012 Oct 27; 14(5):445-51. PubMed ID: 22970743
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
    Donataccio D, Roggen F, De Reyck C, Verbaandert C, Bodeus M, Lerut J.
    Transpl Int; 2006 Jan 27; 19(1):38-43. PubMed ID: 16359375
    [Abstract] [Full Text] [Related]

  • 19. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
    Ikegami T, Taketomi A, Ohta R, Soejima Y, Yoshizumi T, Harada N, Shimada M, Maehara Y.
    Hepatogastroenterology; 2008 Jan 27; 55(88):2162-5. PubMed ID: 19260497
    [Abstract] [Full Text] [Related]

  • 20. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
    Skagen CL, Jou JH, Said A.
    Clin Transplant; 2011 Jan 27; 25(3):E243-9. PubMed ID: 21323735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.